Colocalization of Kindlin-1, Kindlin-2, and Migfilin at Keratinocyte Focal Adhesion and Relevance to the Pathophysiology of Kindler Syndrome  by Lai-Cheong, J.E. et al.
Colocalization of Kindlin-1, Kindlin-2, and Migfilin at
Keratinocyte Focal Adhesion and Relevance to the
Pathophysiology of Kindler Syndrome
JE Lai-Cheong1,2, S Ussar3, K Arita1, IR Hart2 and JA McGrath1
Kindler syndrome (KS) results from pathogenic loss-of-function mutations in the KIND1 gene, which encodes
kindlin-1, a focal adhesion and actin cytoskeleton-related protein. How and why abnormalities in kindlin-1
disrupt keratinocyte cell biology in KS, however, is not yet known. In this study, we identified two previously
unreported binding proteins of kindlin-1: kindlin-2 and migfilin. Co-immunoprecipitation and confocal
microscopy studies show that these three proteins bind to each other and colocalize at focal adhesion in HaCaT
cells and normal human keratinocytes. Moreover, loss-of-function mutations in KIND1 result in marked
variability in kindlin-1 immunolabeling in KS skin, which is mirrored by similar changes in kindlin-2 and migfilin
immunoreactivity. Kindlin-1, however, may function independently of kindlin-2 and migfilin, as loss of kindlin-1
expression in HaCaT keratinocytes by RNA interference and in KS keratinocytes does not affect KIND2 or
FBLIM1 (migfilin) gene expression or kindlin-2 and migfilin protein localization. In addition to identifying
protein-binding partners for kindlin-1, this study also highlights that KIND1 gene expression and kindlin-1
protein labeling are not always reduced in KS, findings that are relevant to the accurate laboratory diagnosis of
this genodermatosis by skin immunohistochemistry.
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INTRODUCTION
Kindler syndrome (KS; OMIM173650) is a rare autosomal
recessive genodermatosis characterized by blistering in
trauma-prone sites, photosensitivity, poikiloderma, and
mucosal erosions and strictures (Kindler, 1954). The gene
responsible for KS, KIND1, was identified in 2003 (Jobard
et al., 2003; Siegel et al., 2003) and, to date, 32 different
pathogenic KIND1 mutations have been documented (see
Lai-Cheong et al., 2007 for mutation summary and Arita et al.,
2007; Mansur et al., 2007 for additional recent mutations).
The KIND1 gene encodes a 677 amino-acid protein, kindlin-1,
which is expressed mainly in basal keratinocytes, colon,
kidney, and placenta (Siegel et al., 2003). Kindlin-1 has been
shown to associate with vinculin in the epithelial cell line
PtK2 transiently transfected with EGFP-kindlin-1 and, to some
extent, with filamentous actin (Siegel et al., 2003). Kindlin-1
forms complexes with b1- and b3-integrin cytoplasmic tails
(Kloeker et al., 2004), and a reduction in kindlin-1 expression
by RNA interference (RNAi) in HaCaT cells results in
decreased cell spreading (Kloeker et al., 2004).
Kindlin-1 forms part of a family of kindlin proteins that
includes two other members: kindlin-2 and kindlin-3 (Siegel
et al., 2003). Kindlin-2 (also known as mitogen inducible
gene-2; Mig2) associates with actin stress fibers and thus is a
component of cell-extracellular matrix adhesion structures
(Tu et al., 2003). RNAi studies, resulting in the knockdown of
kindlin-2 expression in HeLa cells, have shown that kindlin-2
is required for the control of cell spreading, probably via
integrin-linked kinase (Tu et al., 2003). Kindlin-2 has also
been demonstrated to associate with and recruit migfilin at
cell-matrix adhesions (Tu et al., 2003). Kindlin-3 is expressed
in pulmonary and hematopoetic tissues but, thus far, has no
known binding partners (Ussar et al., 2006). Migfilin is a
novel LIM-containing protein that localizes to cell-matrix
adhesions and associates with actin via its N-terminal domain
while interacting with kindlin-2 through its C-terminal
domain (Tu et al., 2003). Like kindlin-2, migfilin is critical
for the control of cell shape (Tu et al., 2003) and has been
shown to bind to filamin and vasodilator-stimulated phos-
phoprotein (Zhang et al., 2006).
In this study, we have identified two key binding partners
of kindlin-1, namely kindlin-2 and migfilin, and demonstrate
both their tissue and cellular distribution. Furthermore, we
have shown that not every patient with KS with pathogenic
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KIND1 mutations has reduced immunolabeling for kindlin-1,
with some individuals having normal levels of kindlin-1
expression and yet suffering from KS. These observations
provide further insight into the role of kindlin-1 in pathophy-
siology of KS.
RESULTS
Clinical features of KS patients
The clinical features of the 13 patients with KS assessed in this
study are summarized in Table 1. All these individuals have
previously determined loss-of-function mutations on both
KIND1 alleles.
Immunoblotting reveals expression of kindlin-1, kindlin-2, and
migfilin in HaCaT cells, normal human keratinocytes (NHK),
and KS keratinocytes
Western blotting showed that kindlin-1, kindlin-2, and
migfilin were expressed in both HaCaT cells, a spontaneously
immortalized human keratinocyte cell line (Boukamp et al.,
1988), and in NHK. Discrete bands of B77 kDa were noted
for both kindlin-1 (Figure 1a, lanes H and NHK) and kindlin-2
(Figure 1b, lanes H and NHK) and an B50 kDa band was
detected for migfilin (Figure 1c, lanes H and NHK) in HaCaT
and NHK lysates. Additionally, in HaCaT lysate, there was an
B74 kDa band that may correspond to the dephosphorylated
form of the kindlin-1 protein (Herz et al., 2006). In KS
keratinocyte lysate, there was loss of the B77 kDa band, a
finding that confirmed the specificity of this kindlin-1 protein
band (Figure 1a, lane KS). In the same KS lysate, however, a
different B65 kDa protein band was observed. Although the
nature of this band is currently unknown, it may correspond
to a truncated or alternatively spliced form of the protein.
Co-immunoprecipitation studies identify kindlin-1, kindlin-2,
and migfilin as potential biochemical partners
We focused on kindlin-2 and migfilin as potential kindlin-1-
binding partners, as they have previously been shown to be
components of cell-matrix adhesions as well as being
Table 1. Summary of ethnicity, clinical features, KIND1 mutations, and skin immunostaining patterns for
anti-kindlin-1, anti-kindlin-2, and anti-migfilin antibodies in 13 patients with KS
Immunolabeling
Patient
KIND1
mutations Blistering
Skin
atrophy
Poikilo-
derma
Photo-
sensitivity
Gingival
inflammation
Urethral
stenosis
Kindlin-
1
Kindlin-
2 Migfilin Reference
Indian p.C468X/
p.C468X
Y Y Y Y Y Y ± ++  Sethuraman
et al., 2005
Indian p.E516X/
p.E516X
Y Y Y N Y N ± ++  Lai-Cheong
et al., 2007
Omani p.R271X/
p.R271X
Y Y Y Y N Y + +  Siegel et al.,
2003
Omani p.W616X/
p.W616X
Y Y Y Y N Y + + + Ashton et al.,
2004
Omani p.W616X/
p.W616X
Y Y Y Y N Y + ++ + Ashton et al.,
2004
Brazilian c.676insC/
c.676insC
Y Y Y Y Y Y + ++ ± Martignago
et al., 2007
US Caucasian p.R271X/
c.1755delT
Y Y Y NK Y Y + ++  Siegel et al.,
2003
US Caucasian p.E304X/
c.1188insT
Y Y Y Y NK Y +++ +++ +++ Ashton et al.,
2004
US Caucasian p.E304X/
c.1161delA
Y Y Y Y Y Y +++ ++ ++ Ashton et al.,
2004
UK Caucasian p.E304X/
c.1909delA
Y Y Y N Y Y ++ +++ +++ Ashton et al.,
2004
UK Caucasian p.R288X/
p.R288X
Y Y Y Y NK Y +++ +++ +++ Siegel et al.,
2003
UK Caucasian p.E304X/
p.L302X
Y Y Y N Y N +++ +++ +++ Ashton et al.,
2004
Italian IVS7-1G4A/
IVS7-1G4A
Y Y Y Y Y Y +++ +++ +++ Ashton et al.,
2004
NHS WT/WT N N N N N N +++ +++ +++
N, no; NK, not known; NHS, normal human skin; Y, yes; WT, wild type.
+++, bright immunostaining; ++, slight reduction in immunoreactivity; +, marked reduction in immunostaining; ±, barely detectable immunolabeling;
, complete absence of labeling.
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biochemically related to each other (Tu et al., 2003; Wu
2005). To determine whether these three proteins are
biochemical partners, co-immunoprecipitation was per-
formed on HaCaT cell lysates, which were precipitated
separately with anti-kindlin-1, anti-kindlin-2, and anti-migfi-
lin antibodies. When anti-kindlin-1 antibody was used to
probe the blot, an B77 kDa band was detected not only for
kindlin-1 but also for kindlin-2 and migfilin (Figure 2a).
Similar patterns of reactivity were observed when anti-
kindlin-2 antibody was used to probe the blot (Figure 2b).
In both blots, there were protein bands atB50 andB25 kDa
corresponding to the molecular weight of heavy- and light-
chain immunoglobulins, respectively. Western blotting of the
same immunoprecipitates using a rabbit polyclonal anti-
collagen VII antibody as an irrelevant antibody control
showed the absence of protein bands at B77 kDa but the
continued presence of bands corresponding to the heavy- and
light-chain immunoglobulins, respectively (Figure 2c).
Confocal microscopy studies show that kindlin-1, kindlin-2, and
migfilin colocalize at focal contacts in NHK and HaCaT cells
To determine whether kindlin-1 colocalizes with its two
biochemical partners, confocal microscopy studies were
performed on NHK individually labeled with anti-kindlin-1,
anti-kindlin-2, or anti-migfilin antibody. Focal adhesions
were revealed by double-staining the cells with anti-vinculin
antibody. In NHK, kindlin-1 showed diffuse cytoplasmic
expression and punctate nuclear localization and colocalized
with vinculin (Figure 3a). In addition, kindlin-2 and migfilin
were expressed in the cytoplasm as well as at focal adhesions
(Figures 3b and c). The independent colocalization of kindlin-1,
kindlin-2, and migfilin with vinculin suggests that all three
proteins may colocalize with each other. To assess this, con-
focal microscopy imaging was performed on HaCaT cells co-
transfected with EGFP-kindlin-1 (Figure 4a) and FLAG-migfilin
(Figure 4b) and then immunostained with anti-kindlin-2 anti-
body (Figure 4c). The merged image showed that the three
proteins colocalized at focal adhesions (Figure 4d).
Confocal microscopy studies on primary KS keratinocytes
show loss of kindlin-1 expression at focal adhesions but
presence of kindlin-2 and migfilin
To explore the pathophysiological role of kindlin-1 and its
two potential binding partners in KS, confocal microscopy
analysis was performed on primary KS keratinocytes (harbor-
ing compound heterozygous KIND1 mutations, p.E304X/p.
L302X) immunolabeled separately with anti-kindlin-1, anti-
kindlin-2, and anti-migfilin antibodies. In these KS keratino-
cytes, kindlin-1 no longer colocalized with vinculin at focal
adhesions despite cytoplasmic expression being present.
However, nuclear localization of kindlin-1 was still present
in these cells (Figure 3d). In contrast, kindlin-2 and migfilin
still colocalized with vinculin at focal adhesion (Figures 3e
and f).
Knockdown of kindlin-1 by RNAi does not alter expression
of kindlin-2 or migfilin in HaCaT cells
To understand the consequences of loss of kindlin-1
expression on kindlin-2 and migfilin, an RNAi study was
performed in HaCaT cells using kindlin-1 (k) and scrambled
control (s) small interfering RNAs (siRNAs) at a concentration
of 100 nM. A gradual reduction in kindlin-1 expression was
observed from day 2 post-transfection to almost complete
knockdown at day 8 (Figure 5a). However, the reduction of
kindlin-1 did not alter the expression of kindlin-2 (Figure 5b).
An increase in migfilin expression was noted from day 6 post-
transfection in both the scrambled and kindlin-1-transfected
HaCaT cells, as well as in the oligofectamine-transfected cells
(Figure 5c). This was confirmed by optical densitometry
analysis using ImageJ software (http://rsb.info.nih.gov/ij/),
which showed up to a fourfold increase in migfilin compared
with day 2 transfected cells (data not shown). The increase in
migfilin expression occurred in both the scrambled control
and kindlin-1-transfected cells, suggesting therefore that it is
not a consequence of kindlin-1 knockdown.
Kindlin-2 and migfilin localization is unchanged following
kindlin-1 siRNA transfection of HaCaT keratinocytes
Confocal microscopy studies performed on kindlin-1 siRNA-
treated HaCaT keratinocytes showed loss of kindlin-1 locali-
zation at focal adhesions (Figure 6a, arrows). However, diffuse
cytoplasmic staining of kindlin-1 was still seen. In contrast,
kindlin-2 and migfilin still colocalized at focal adhesions
(Figures 6b and c). In the scrambled control siRNA-treated
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Figure 1. Immunoblotting shows different expression patterns of kindlin-1
(but not kindlin-2 or migfilin) in KS or control keratinocytes. Immunoblotting
shows (a)B77 andB74 kDa protein bands matching the molecular weight of
kindlin-1 and its dephosphorylated form in HaCaT cell lysate (lane H). The
same B77 kDa band was present in lane NHK but absent in lane KS. In
addition, anB65 kDa band was seen in lane KS. (b) In lanes H, NHK, and KS,
an B77 kDa band corresponding to the molecular weight of kindlin-2 was
seen. (c) AnB50 kDa band that equates to the expected molecular weight of
migfilin was observed in lanes H, NHK, and KS. H, HaCaT cell lysate; NEG,
negative control; NHK, normal human keratinocytes; KS, Kindler syndrome.
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Figure 2. Co-immunoprecipitation studies show that kindlin-1, kindlin-2, and migfilin can bind to each other. (a) Western blotting on the immunoprecipitates
using anti-kindlin-1 antibody shows B77 kDa bands in all three lanes, indicating that kindlin-1 forms a complex with kindlin-2 and migfilin. (b) Similarly,
western blotting using anti-kindlin-2 antibody reveals B77 kDa bands in all three lanes, indicating that kindlin-2 associates with kindlin-1 and migfilin.
(c) Immunoblotting performed using rabbit polyclonal anti-collagen VII IgG antibody as irrelevant antibody control shows absence of the B77 kDa protein
band but persistence of the B50 and B25 kDa bands.
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Figure 3. Confocal microscopy studies show different kindlin-1 localization but preserved kindlin-2 and migfilin localization in NHK and KS keratinocytes,
respectively. (a) In NHK, kindlin-1 was expressed both in the cytoplasm and near the cell periphery and colocalized with vinculin at focal adhesions.
Similarly, both (b) kindlin-2 and (c) migfilin showed cytoplasmic and peripheral distribution and colocalized with vinculin. (d) In KS keratinocytes, there
was cytoplasmic localization of kindlin-1 but kindlin-1 expression at focal adhesions was absent, as evidenced by the lack of colocalization with vinculin.
In contrast, (e) kindlin-2 and (f) migfilin subcellular localization was not affected. Bar¼20 mm.
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cells, colocalization of kindlin-1, kindlin-2, and migfilin with
vinculin at focal adhesions was still present, with no change
in the protein distribution or appearances of focal adhesions
(Figures 6d–f).
Immunofluorescence microscopy shows highly variable
kindlin-1 immunostaining in KS patients with pathogenic
KIND1 mutations
To determine the tissue distribution of kindlin-1, immuno-
fluorescence microscopy labeling was performed in both
normal and KS frozen skin sections. In normal skin sections
immunolabeled with anti-kindlin-1 antibody, there was
bright staining near the cell periphery in the basal keratino-
cytes (arrows) as well as less intense labeling throughout the
epidermis (Figure 7a). Frozen skin sections from 13 patients
with KS with pathogenic KIND1 mutations were immuno-
labeled for kindlin-1. A surprising finding was that not every
patient showed reduced or absent anti-kindlin-1 immuno-
staining. In fact, kindlin-1 labeling was markedly reduced in
seven patients (Figure 7b) and was normal or only slightly
reduced in six patients with KS (Figure 7c). The immuno-
fluorescence microscopy data are summarized in Table 1.
Immunolabeling for kindlin-2 and migfilin in KS skin mirrors
the variable kindlin-1 immunostaining patterns
Immunostaining with anti-kindlin-2 antibody on frozen
normal skin sections showed pan-epidermal membranous
labeling but with no staining along the lower pole of
basal keratinocytes in contact with the basement membrane
(Figure 7d). Anti-migfilin antibody labeling on frozen normal
skin sections showed basal epidermal staining near the cell
periphery with sparing of the rest of the epidermis (Figure 7g).
Of note, there was a reduction of immunolabeling for
kindlin-2 (Figure 7e) and also migfilin (Figure 7h) in the
seven patients with KS with reduced anti-kindlin-1 labeling.
However, in the six patients in whom kindlin-1 labeling was
normal or slightly reduced, kindlin-2 and migfilin immuno-
staining was of normal or near-normal intensity (Figures 7f
and i). Table 1 provides a summary of the immunolabeling
data.
Semi-quantitative reverse transcriptase PCR (RT-PCR) shows
variable reduction in KIND1 mRNA expression but normal
KIND2 and FBLIM1 (migfilin) mRNA levels
To begin to understand why some patients with KS have
reduced or almost normal anti-kindlin-1 immunostaining
patterns, we assessed KIND1 mRNA expression in four
patients with KS, all of whom had pathogenic KIND1
mutations determined in their genomic DNA. RT-PCR was
performed using cDNA synthesized from skin samples from
three patients with reduced or absent anti-kindlin-1 immu-
nolabeling and one patient with near-normal immunostain-
ing, respectively. The three patients harboring the following
homozygous nonsense mutations p.E516X/p.E516X,
p.W616X/p.W616X, and p.R271X/p.R271X all had reduced
anti-kindlin-1 immunolabeling and were found to have
correspondingly decreased expression of full-length KIND1
mRNA (Figure 8a, lanes 4–6). The reduction in KIND1 mRNA
in these cases is consistent with nonsense-mediated RNA
decay (Nagy and Maquat, 1998; Frischmeyer and Dietz,
1999; Holbrook et al., 2004; Maquat 2004), notwithstanding
that the mutation p.W616X occurs close to the 30 end of the
penultimate KIND1 exon (exon 14). Whole skin cDNA was
EGFP-kindlin-1 FLAG-migfilin
MergedEndogenous kindlin-2
Figure 4. Confocal microscopy shows that kindlin-1, kindlin-2, and migfilin
all colocalize at focal adhesions. (a) Kindlin-1 localizes to the ends of actin
stress fibers and also demonstrates a perinuclear distribution. (b) Migfilin is
distributed both in the cytoplasm and at the cell periphery. (c) Endogenous
kindlin-2 also localizes to the ends of actin stress fibers. (d) Merged
confocal image shows colocalization of kindlin-1, kindlin-2, and migfilin
at focal adhesions as shown by the white staining at the cell periphery
(arrows). Bar¼20 mm.
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Figure 5. Kindlin-2 and migfilin expression is not altered after RNAi-mediated
knockdown of kindlin-1 in HaCaT cells. (a) Gradual reduction of kindlin-1
expression was noted from day 2 post-transfection. (b) Expression of kindlin-2
does not seem to be altered by kindlin-1 knockdown. (c) However, there was
an increase in migfilin expression from day 6 post-transfection in the scrambled
control and kindlin-1-transfected HaCaT cells. Oligofectamine-only
(OLI)-treated HaCaT keratinocytes lysate was used as control and showed
no reduction in kindlin-1 expression. In contrast, no reduction in kindlin-1
expression was seen when the cells were treated with scrambled siRNA.
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available only from one patient with normal kindlin-1
immunostaining (harboring the compound heterozygous
mutations p.E304X/c.1909delA) who was subsequently found
to have normal expression of KIND1 mRNA (Figure 8,
lane 7). However, all four patients had normal levels of
KIND2 and FBLIM1 (migfilin) mRNA levels compared with
normal controls (Figures 8b and c) despite the individuals
in lanes 4–6 showing reduced kindlin-2 and migfilin labeling
on skin sections (cf. Figure 7e and h).
DISCUSSION
In this study, we have identified kindlin-2 and migfilin as two
novel biochemical partners of kindlin-1 by co-immuno-
precipitation supported by confocal microscopy imaging
on NHK, KS keratinocytes, as well as on transfected HaCaT
cells. Previous studies have established the colocalization of
kindlin-1 with other focal adhesion proteins such as paxillin
in various cell types including mouse embryonic fibro-
blasts (Ussar et al., 2006) and the epithelial cell line PtK2
(Siegel et al., 2003). However, our confocal microscopy
studies provide novel in vitro data regarding the localization
of kindlin-1, kindlin-2, and migfilin in both NHK and KS
keratinocytes. Additionally, we have shown that loss of
kindlin-1 in both KS keratinocytes and kindlin-1 siRNA-
transfected HaCaT cells does not seem to alter the expression
or localization of either kindlin-2 or migfilin at focal adhesions.
Our study also identifies a potential pitfall in using
immunofluorescence microscopy to assist the clinical diag-
nosis of KS. Previously, our group has reported the usefulness
of immunofluorescence microscopy on frozen skin sections
in making a rapid diagnosis of KS (Ashton et al., 2004; Fassihi
et al., 2005; Burch et al., 2006; Arita et al., 2007). Although it
remains an invaluable tool, immunostaining of a larger
number of cases now highlights that some patients with KS,
with loss-of-function KIND1 mutations confirmed by gene
sequencing, have almost normal anti-kindlin-1 immuno-
staining. Thus, positive anti-kindlin-1 immunolabeling does
not rule out a diagnosis of KS, and therefore KIND1 gene
sequencing remains the gold standard in diagnosing this
condition. An explanation for the positive anti-kindlin-1
antibody labeling may be gleaned from immunoblotting data
comparing kindlin-1 expression in NHK and KS lysates
(obtained from an individual with KS harboring compound
heterozygous KIND1 mutations, p.E304X/p.L302X). In this
individual, positive anti-kindlin-1 skin immunolabeling was
observed, which may reflect the presence of the B65 kDa
DAPI
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DAPI
Kindlin-1 siRNA-treated
Scrambled siRNA-treated
DAPIKindlin-1
DAPI
Vinculin Merged
Kindlin-1
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Vinculin Merged
DAPI Kindlin-2
Migfilin
Vinculin Merged
DAPI Migfilin
Figure 6. Kindlin-2 and migfilin localization remains unchanged in kindlin-1 siRNA-transfected HaCaT keratinocytes. (a) In HaCaT keratinocytes
transfected with kindlin-1 siRNA, there was no localization of kindlin-1 at focal adhesions (arrows). However, (b) kindlin-2 and (c) migfilin still colocalized
with vinculin at focal adhesions. In contrast, in the scrambled control-transfected HaCaT cells, there was no change in (d) kindlin-1, (e) kindlin-2, and
(f) migfilin subcellular localization. Bar¼20 mm.
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protein band detected by immunoblotting. Although the
nature of this band is currently unknown, it could correspond
to either a smaller kindlin-1 isoform or a truncated form of the
protein, or it could represent nonspecific antibody binding.
The immunofluorescence data also raise several key
points. First, there does not appear to be any clear correlation
between the site or nature of the mutations, immunostaining
patterns, and specific clinical features of the disease. For
instance, the patients with the homozygous nonsense
mutations p.R271X/p.R271X and p.R288X/p.R288X might
be predicted to have similar immunostaining patterns, but our
results suggest otherwise. Secondly, the seven patients with
reduced or absent anti-kindlin-1 immunostaining had similar
clinical features to those with positive immunolabeling,
observations which suggest that the low levels of kindlin-1
expression or normally expressed but defective kindlin-1
protein are insufficient to maintain normal skin integrity and
homeostasis. Thirdly, it appears that patients of Caucasian
background have more positive anti-kindlin-1 immunostaining
compared with other affected individuals (for example,
from the Middle East, South America, or Asia), suggesting
that the diverse ethnic, geographical, and environmental
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Figure 7. Immunofluorescence microscopy shows two patterns of labeling for kindlin-1, kindlin-2, and migfilin in KS skin. (a) Immunolabeling with
anti-kindlin-1 antibody on normal skin sections shows bright epidermal staining predominantly at the cell periphery (but also in the cytoplasm) mostly
within the basal keratinocyte layer (arrows) but with less intense pan-epidermal labeling. (b) In the KS patient with the homozygous nonsense mutation
p.E516X/p.E516X there is barely detectable staining for kindlin-1. (c) In contrast, in the KS patient with the homozygous mutation p.R288X/p.R288X there is
similar kindlin-1 immunolabeling intensity to control skin (cf. Figure 7a). (d) Anti-kindlin-2 immunostaining of normal skin sections shows pan-epidermal
membranous labeling with the absence of staining being noted along the lower pole of basal keratinocytes. (e) Marked reduction in anti-kindlin-2 antibody
immunoreactivity is seen in the patient’s skin harboring the homozygous nonsense mutation p.E516X/p.E516X. (f) Kindlin-2 antibody labeling in the
patient with the homozygous nonsense mutation p.R288X/p.R288X is similar to that in normal skin. (g) Anti-migfilin staining of normal skin sections shows
membranous and cytoplasmic labeling of the basal keratinocytes. (h) Anti-migfilin antibody labeling in the patient with homozygous nonsense mutation
p.E516X/p.E516X shows barely detectable labeling. (i) Anti-migfilin antibody labeling in the patient with the homozygous nonsense mutation p.R288X/p.R288X
is similar to that in normal skin. White dashed lines indicate the position of the dermal–epidermal junction in (b), (e), and (h). Bar¼ 50 mm.
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Figure 8. Semi-quantitative RT-PCR shows correlation between KIND1
mRNA expression and the corresponding kindlin-1 labeling patterns.
(a) Compared with the three normal controls (lanes 1–3), patients with
reduced anti-kindlin-1 immunostaining (lanes 4–6) had variably reduced
KIND1 mRNA levels, whereas the patient with normal immunolabeling of
anti-kindlin-1 (lane 7) had a normal or near-normal level of KIND1 mRNA.
(b) Patients with reduced kindlin-2 labeling (lanes 4–6), however, had no
reduction in KIND2 mRNA expression compared with normal controls
(lanes 1–3) or the patient with normal kindlin-2 immunostaining (lane 7).
(c) Similarly, there was no difference in FBLIM1 mRNA expression
in any of the patients compared with normal controls. (d) GAPDH
mRNA expression was used as loading control in these
experiments.
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backgrounds of the cases studied may also have an impact on
phenotype and expression of kindlin-1. Fourthly, although
skin immunolabeling reveals a mirror effect for kindlin-1,
kindlin-2, and migfilin immunolabeling (that is, a reduction
of kindlin-1 labeling is paralleled by a decrease in both
kindlin-2 and migfilin labeling), kindlin-2 or migfilin expres-
sion and localization were still demonstrated by immuno-
blotting and confocal microscopy, respectively.
KIND1 mRNA expression was variably reduced in the
three patients with reduced anti-kindlin-1 labeling. However,
the individual harboring the compound heterozygous muta-
tions p.E304X/c.1909delA (normal anti-kindlin-1 labeling)
had near-normal KIND1 mRNA expression. In this case, we
anticipated KIND1 mRNA expression to beB50% of normal,
as the mutation c.1909delA occurs in the last exon of KIND1
and is therefore unlikely to be affected by nonsense-mediated
mRNA decay. However, KIND1 mRNA levels were normal,
suggesting that the other mutation p.E304X in exon 7 also
does not seem to affect the stability of KIND1 mRNA. No
evidence for alternative splicing of KIND1 was detected in
this individual, and thus an adequate explanation for the
near-normal mRNA levels is lacking.
The identification of kindlin-2 and migfilin as binding
partners of kindlin-1 provides new insight into the patho-
physiology of KS. First, it is evident that not all cases of KS
harbor pathogenic mutations in KIND1—perhaps B25% of
cases may result from mutations in other, as yet unidentified,
candidate genes (JAM, unpublished data). It is therefore
plausible that some individuals with KS or a KS-like geno-
dermatosis might have underlying pathogenic mutations in
KIND2 or FBLIM1. Secondly, the biochemical association
of these proteins provides new information regarding the role
of focal adhesion proteins in the pathogenesis of skin disease
and helps us understand further the pathophysiology of KS.
MATERIALS AND METHODS
Antibodies
A rabbit polyclonal anti-kindlin-1 antibody that recognizes the
last 277 amino-acid residues of kindlin-1 was kindly supplied by
Dr Mary Beckerle (Salt Lake City, OH). Rabbit polyclonal anti-
kindlin-2 and anti-migfilin antibodies were supplied by Reinhard
Fa¨ssler (Max Planck Institute of Biochemistry, Martinsried,
Germany). Alexa Fluor 488 goat anti-rabbit IgG secondary antibody
(Invitrogen, Eugene, OR) was used for immunofluorescence labeling
on skin sections. For cell immunofluorescence staining, mouse
monoclonal anti-vinculin (Sigma-Aldrich, St Louis, MO) and
anti-FLAG M2 antibodies (Sigma-Aldrich) were used. Alexa Fluor
546 goat anti-mouse IgG and Alexa Fluor 647 goat anti-rabbit
IgG secondary antibodies (Invitrogen), both highly cross-adsorbed,
were used in cell immunofluorescence microscopy.
Skin biopsies
Skin biopsies were taken for immunofluorescence microscopy
studies, tissue culture, and nucleic acid extraction after written,
informed consent was obtained from each patient, in accordance
with the Ethics Committee approval from the Guy’s and St Thomas’
Hospital. The study was conducted according to the Declaration of
Helsinki principles.
Western blotting
Keratinocytes were lysed with NuPage LDS sample buffer (Invitro-
gen, Carlsbad, CA) and 10% 2-mercaptoethanol (Sigma-Aldrich).
The lysates were then loaded and run on NuPage 4–12% bis-Tris gels
(Invitrogen) at 150V for 1.5 hours. The proteins were then transferred
onto Hybond-ECL nitrocellulose membranes (Amersham Bio-
sciences, Little Chalfont, UK) and blocked in 5% skimmed milk in
0.1% Tween-20 (Sigma-Aldrich) and Tris-buffered saline. The
membranes were then probed with anti-kindlin-1, anti-kindlin-2,
and anti-migfilin antibodies overnight at 41C. Mouse monoclonal
anti-b actin (Sigma-Aldrich) was used as loading control. Anti-rabbit
horseradish peroxidase-conjugated IgG antibody was used as
secondary antibody. Visualization of protein bands was done with
ECL western blotting detection reagents (Amersham Biosciences).
Co-immunoprecipitation
For co-immunoprecipitation, confluent HaCaT cell culture in 75 cm2
flask was lysed with 500 ml of Ripa (Radioimmunoprecipitation
assay) lysis buffer (Upstate Cell Signaling Solutions, Charlottesville,
VA) containing 5 ml of 100mM protease inhibitor cocktail set
(Merck Bioscience, Nottingham, UK) and 5 ml of 100mM sodium
orthovanadate at 41C for 5minutes. Following centrifugation, the
supernatant was precleared with Trueblot anti-rabbit Ig immuno-
precipitation beads (Insight Biotechnology Ltd, Middlesex, UK) for
30minutes at 41C. The beads were then removed by centrifugation
and the supernatant was mixed separately with anti-kindlin-1,
anti-kindlin-2, and anti-migfilin antibodies for 1 hour at 41C.
Subsequently, Trueblot anti-rabbit Ig immunoprecipitation beads
were added to the immunoprecipitates and incubated on ice for a
further hour. The beads were then collected by centrifugation and
washed three times with Ripa buffer before proceeding with western
blotting. Rabbit Trueblot HRP-conjugated anti-rabbit IgG was used
as secondary antibody (Insight Biotechnology Ltd). Visualization of
protein bands was achieved with ECL western Blotting detection
reagents.
Plasmid transfection of HaCaT cells
EGFP-kindlin-1, EGFP-kindlin-2, and FLAG-migfilin were supplied
by Professor Reinhard Fa¨ssler. EGFP-kindlin-1 and EGFP-kindlin-2
were cloned as described previously (Ussar et al., 2006). HaCaT
keratinocytes, at a seeding density of 2 105 cells per well on
13mm diameter coverslips in a 6-well plate, were transfected with
EGFP-kindlin-1 and FLAG-migfilin. Briefly, 1 mg of each plasmid was
mixed with 500ml of Optimem (Gibco, Paisley, UK) and incubated
for 5minutes at room temperature. A volume of 5 ml of oligofecta-
mine (Invitrogen) was added to 500ml optimem and the mixture was
incubated for 5minutes at room temperature. The two solutions were
then mixed, incubated for a further 20minutes at room temperature
before being added to the HaCaT keratinocytes, and incubated at
371C for 4 hours.
Cell immunofluorescence microscopy
For immunofluorescence, the fixed cells (fixation achieved using
either 4% formaldehyde for 10minutes at room temperature or an
equal mixture of methanol/acetone for 10minutes at 201C) were
blocked with 10% goat serum (Sigma-Aldrich) and 0.3% BSA in
phosphate-buffered saline by incubation with primary antibody.
Secondary antibody incubation was performed for 1 hour at room
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temperature. The coverslips containing the fixed immuno-
labeled cells were mounted with Prolong Gold AntiFade Reagent
(Invitrogen) onto Superfrost Plus slides (VWR) and analyzed with a
Zeiss Axioplan 2 Imaging confocal microscopy system.
RNA interference
Kindlin-1 expression was knocked down by RNAi using kindlin-1
siRNA (Dharmacon/Perbio, Cramlington, UK) as described previously
(Kloeker et al., 2004). Preparation of the transfectants involved incu-
bating each siRNA with Optimem for 5minutes at room temperature
before adding the mixture to an oligofectamine/Optimem solution.
The cells were incubated for 4 hours with this transfection mixture.
Immunofluorescence microscopy
Five-micrometer-thick frozen skin sections were cut from skin biopsies
obtained from 13 patients with KS in whom loss-of-function muta-
tions in KIND1 had been determined. The sections were blocked
with 10% goat serum for 30minutes followed by incubation with
the primary antibody for 30minutes at 371C. Secondary antibody
incubation was performed for 30minutes at 371C. Following
phosphate-buffered saline wash, the sections were air-dried and
mounted with Vectashield Hard Set with DAPI (Vector Laboratories,
Peterborough, UK) and viewed under a fluorescent microscope.
Extraction of total RNA from skin biopsies and cDNA synthesis
Skin biopsies were taken from patients with KS harboring
the mutations p.E516X/p.E516X, p.W616X/p.W616X, p.R271X/
p.R271X, and p.E304X/c.1909delA, and stored in RNAlater (Qiagen,
Crawley, UK) before processing. Total RNA was extracted from each
skin biopsy using the RNeasy Fibrous Tissue Mini Kit (Qiagen).
First-strand cDNA synthesis was performed with 2mg of total RNA
using SuperScript II Reverse Transcriptase (Invitrogen).
Semi-quantitative PCR analysis
First-strand cDNA was amplified by PCR in a reaction volume
consisting of 2ml of 2.5 M dNTP, 2ml forward and reverse primers,
1ml of cDNA, 10.375 ml water, 0.125 ml of Taq polymerase, 5ml Q
buffer, and 2.5 ml of 10 buffer. All PCR reagents were purchased
from Qiagen. Details of KIND1, KIND2, and FBLIM1 cDNA primers
are as follows: KIND1 forward cDNA primer: 50-TCAAACAGTGGA
ATGTAAACTGG-30; KIND1 reverse cDNA primer: 50-TACATGCTG
GGCACGTTAGG-30; KIND2 forward cDNA primer: 50-GAACAAGC
AGATAACAGC-30; KIND2 reverse cDNA primer: 50-CGGTGACCAT
TTTGATTTCCC-30; FBLIM1 forward cDNA primer: 50-AAAATCGAA
TGCATGGGAAG-30; FBLIM1 reverse cDNA primer: 50-GCAGGTTA
GGAAGGGAAACC-30. All the primer pairs were designed to
amplify a region in the 30 UTR of each gene and were purchased
from MWG (Ebelsberg, Germany). To ensure equal loading, a
housekeeping gene (GAPDH) was simultaneously amplified. The
PCR products were assessed on a 2% agarose gel.
HaCaT culture
The HaCaT cell line was grown to 70–80% confluence in DMEM
(Invitrogen) and 10% fetal bovine serum (Invitrogen).
Primary keratinocyte culture
Skin biopsies were incubated overnight at 41C with dispase I
(dilution 34U in 20ml phosphate-buffered saline) (Roche Applied
Science, Burgess Hill, UK). The detached epidermal sheet was then
incubated with a 0.05% tryspin/EDTA solution (Invitrogen) for
15minutes at 371C. The solution was subsequently filtered through a
100mm cell strainer (VWR International, Lutterworth, UK) and the
released keratinocytes were centrifuged at 1200 r.p.m. for 5minutes.
The cell pellet was resuspended in Epilife Basal Medium (Cascade
Biologics, Mansfield, UK) supplemented with Epilife Defined
Growth Supplement and Gentamicin/Amphotericin B (Cascade
Biologics) and plated in T25 flasks previously treated with Coating
Matrix (Cascade Biologics).
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